Cognivia

Mont-saint-guibert, Belgium

Cognivia develops analytical tools to optimize and speed the clinical development of novel medicines.

$16.5M raised

Apr 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cognivia raised?

Cognivia has raised $16.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2024.

Who are Cognivia's investors?

Cognivia's investors include Vesalius Biocapital Partners, SFPIM, Innovation Fund, WE International, Sambrinvest.

Where is Cognivia headquartered?

Cognivia is headquartered in Mont-saint-guibert, Belgium.

What does Cognivia do?

Cognivia develops analytical tools to optimize and speed the clinical development of novel medicines.

What stage is Cognivia at?

Cognivia is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 18, 2024.

MLA

"Cognivia — Funding & Investors." VCBacked, April 18, 2024, https://www.vcbacked.co/company/cognivia. Accessed July 4, 2026.

APA

VCBacked. (2024). Cognivia — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/cognivia

Wikipedia (cite web)

{{cite web |title=Cognivia — Funding & Investors |url=https://www.vcbacked.co/company/cognivia |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 18, 2024.